Biopharma’s greatest hits of the 2010s
(HYACINTH EMPINADO/STAT)
Depending on the year, we read that the FDA is approving too many drugs or too few drugs, doing it too quickly or too slowly. Less often discussed, however, is how many of them are any good.
With that in mind, STAT’s Adam Feuerstein and Matthew Herper pored over all of the therapies approved in the past decade with one question in mind: Which of these treatments truly mattered? And they came up with 10 drugs that changed the industry, pushed medicine forward, and, in one case, actually cured a disease.
You can find their list here, and you can air your grievances with it by replying to this email or by hounding the authors on Twitter.
With that in mind, STAT’s Adam Feuerstein and Matthew Herper pored over all of the therapies approved in the past decade with one question in mind: Which of these treatments truly mattered? And they came up with 10 drugs that changed the industry, pushed medicine forward, and, in one case, actually cured a disease.
You can find their list here, and you can air your grievances with it by replying to this email or by hounding the authors on Twitter.
.png)
No hay comentarios:
Publicar un comentario